08/03/2019 21:30:36

Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Maiden Holdings, Ltd. (MHLD)

LOS ANGELES, March 08, 2019 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the April 12, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Maiden Holdings, Ltd. (“Maiden” or the “Company”) (NASDAQ: MHLD) securities between March 4, 2014 and November 9, 2018, inclusive (the “Class Period”). Maiden investors have until April 12, 2019 to file a lead plaintiff motion.

If you are a shareholder who suffered a loss, click here to participate.

If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, at 310-201-9150, Toll-Free at 888-773-9224, or by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com.

On November 9, 2018, Maiden revealed its financial results for the quarter ended September 30, 2018, including a significant $308.8 million loss and a $210.4 million adverse prior year loss development in its AmTrust segment. Maiden also stated that the sale of its business assets resulted in an impairment loss of $74.2 million. On this news, shares of Maiden fell nearly 32% to close at $2.40 per share on November 12, 2018, thereby injuring investors.

The complaint filed in this class action alleges that throughout the Class Period Defendants made false and/or misleading statements and/or failed to disclose that: (1) Maiden lacked adequate underwriting processes and risk management controls necessary to accurately price its reinsurance policies, set appropriate loss reserves and avoid excessive losses; (2) Maiden failed to take steps necessary to properly assess and cross check the insurance portfolio of AmTrust, its largest client and a related entity, to ensure that its reinsurance of AmTrust’s portfolio was properly priced and did not expose Maiden to the risk of excessive losses; (3) Maiden failed to conduct appropriate independent reviews, actuarial analyses and audits of the policies underlying its AmTrust Reinsurance segment, which would have revealed that the risk of loss from these policies was significantly understated; (4) as a result of the foregoing, Maiden was subject to materially heightened risk of financial loss, reserve charges and diminished prospects; and (5) as a result, defendants’ statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Follow us for updates on Twitter: twitter.com/GPM_LLP.

If you purchased shares of Maiden, you may move the Court no later than April 12, 2019 to ask the Court to appoint you as lead plaintiff. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Glancy Prongay and Murray LLP, Los Angeles

Lesley Portnoy, 310-201-9150 or 888-773-9224

www.glancylaw.com

shareholders@glancylaw.com

GPM Logo.jpg

Related content
25 Mar - 
SHAREHOLDER ALERT: GE MHLD KHC CVS: The Law Offices of ..
25 Mar - 
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL:..
25 Mar - 
CLASS ACTION UPDATE for MHLD, KHC, WTW and USX: Levi & ..
Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
UKTW I²P Celebrates First Successful Year of UK-TW Science Research Cooperation
2
ExCellThera announces clearance by FDA and Health Canada for ECT-001 in new clinical trials in United States and Canada for the treatment of leukemia
3
Reminder - Product Tanker, Crude Oil Tanker, LNG, LPG and Chemical Tankers Sector Panel Discussions With Major Shipping Company Executives
4
Invitation by Aperam S.A. to holders of its outstanding U.S.$300,000,000 0.625 per cent. Net Share Settled Convertible and/or Exchangeable Bonds due 2021 (ISIN XS1084287322) (the “Bonds”) convertible into common shares of Aperam S.A. to off
5
Philips expands its radiology solutions offering with advanced teleradiology services

Related stock quotes

Maiden Holdings Ltd 0.7507 3.5% Stock price increasing

Latest news


Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
26 March 2019 03:02:08
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190320.1 - EUROWEB7 - 2019-03-26 04:02:08 - 2019-03-26 03:02:08 - 1000 - Website: OKAY